Isosorbide dinitrate and Linzess drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isosorbide dinitrate (isosorbide dinitrate) and Linzess (linaclotide). Common drug interactions include gastrooesophageal reflux disease among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Isosorbide dinitrate and Linzess. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Isosorbide dinitrate?

Isosorbide dinitrate has active ingredients of isosorbide dinitrate. It is often used in angina. eHealthMe is studying from 13,180 Isosorbide dinitrate users. Check the latest studies of Isosorbide dinitrate.

What is Linzess?

Linzess has active ingredients of linaclotide. It is often used in constipation. eHealthMe is studying from 24,086 Linzess users. Check the latest studies of Linzess.



On Jul, 04, 2026

39 people who take Isosorbide dinitrate and Linzess together, and have interactions are studied.

Isosorbide dinitrate and Linzess drug interactions.

What are the common drug interactions of Isosorbide Dinitrate and Linzess, by gender? *:

female:

  1. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  2. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  3. Hospitalisation
  4. Hypersomnia (excessive daytime sleepiness (eds))
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Injection site haemorrhage (bleeding from injection site)
  7. Ligament sprain (ligament stretched)
  8. Lumbar vertebral fracture
  9. Lung disorder (lung disease)
  10. Lymphadenopathy (disease or enlargement of lymph nodes)

male:

  1. Cardiac failure congestive
  2. Dyspnoea (difficult or laboured respiration)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Dehydration (dryness resulting from the removal of water)
  5. Depressed level of consciousness
  6. Diarrhoea
  7. Dysuria (painful or difficult urination)
  8. Epistaxis (bleed from the nose)
  9. Erythema (redness of the skin)
  10. Haemoglobin decreased

What are the common drug interactions of Isosorbide Dinitrate and Linzess, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Fatigue (feeling of tiredness)
  3. Injection site haemorrhage (bleeding from injection site)

40-49:

  1. Dizziness

50-59:

  1. Blood creatinine increased
  2. Chronic kidney disease
  3. Generalised oedema (swelling all over the body)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Oedema peripheral (superficial swelling)
  6. Renal disorder (kidney disease)
  7. Renal failure (kidney dysfunction)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Dyspnoea (difficult or laboured respiration)
  3. Intracranial aneurysm (bulging, weak area in the wall of a cranial artery)
  4. Anaemia (lack of blood)
  5. Bone cancer metastatic
  6. Cancer pain
  7. Cardiac failure congestive
  8. Cystitis (inflammation of the wall of the bladder)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 28.21%
  2. Immunodeficiency Common Variable: 4 people, 10.26%
  3. Stable Angina (a constant chest pain): 3 people, 7.69%
  4. Immunodeficiency: 3 people, 7.69%
  5. Urinary Tract Infection: 2 people, 5.13%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.13%
  7. Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 5.13%
  8. Pain: 2 people, 5.13%
  9. Nausea (feeling of having an urge to vomit): 2 people, 5.13%
  10. Muscle Aches (muscle pain): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide dinitrate and Linzess?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isosorbide dinitrate and Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isosorbide dinitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide dinitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Linzess and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide dinitrate and linaclotide (the active ingredients of Isosorbide dinitrate and Linzess, respectively), and Isosorbide dinitrate and Linzess (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: